AMN

SEC source: 0001209191-20-002431 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,943

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002431 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-002416 · doc4.xml · derivative · entry 9

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,256

Underlying: Common Stock · 2,096 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs set forth in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002416 · doc4.xml · nonDerivative · entry 2

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,510

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002416 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,352

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-002414 · doc4.xml · derivative · entry 10

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,256

Underlying: Common Stock · 2,096 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The RSUs set forth in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F7 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002414 · doc4.xml · nonDerivative · entry 2

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,999

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002414 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,609

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-19-061066 · doc4.xml · derivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,322 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units set forth in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units were granted on December 17, 2018 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-19-061066 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,984

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-061066 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,865

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-19-061066 · doc4.xml · derivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,755

Underlying: Common Stock · 20,755 shares

Expires not disclosed

F3 · derivative.exercise_price: The Restricted Stock Units set forth in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The Restricted Stock Units were granted on December 16, 2019 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-19-061991 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,513

F1 · kind: The reporting person transferred 1,815 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-18-061946 · doc4.xml · derivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,042 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Deferred Restricted Stock Units ("RSUs") identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Receipt of each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs were granted on December 9, 2015 and vest on the third anniversary of the grant date. Pursuant to the Reporting Person's irrevocable election, the RSUs will settle upon her separation of service from the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-059660 · doc4.xml · derivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,872 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units set forth in this row were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units were granted on December 5, 2016 and vest on the third anniversary of the grant date.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-19-059660 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,543

F3 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-059660 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-19-057544 · doc4.xml · nonDerivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001209191-19-059660 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,555

F1 · kind: The reporting person transferred 8,000 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-19-056262 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,256

F1 · price: The price reported in this row represents a weighted average price of $60.18957 per share. These shares were sold in multiple transactions at prices ranging from $59.78 to $60.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-055783 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,090

F1 · kind: The reporting person transferred 1,800 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-19-055593 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,555

F1 · kind: The sale of 18,156 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $60.1897 per share. These shares were sold in multiple transactions at prices ranging from $59.98 to $60.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-055514 · doc4.xml · nonDerivative · entry 1

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

F1 · price: The price reported in this row represents a weighted average price of $59.8783 per share. These shares were sold in multiple transactions at prices ranging from $59.87 to $59.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-050120 · doc4.xml · derivative · entry 1

Fontenot Teri G. · CIK 0001661066 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,356

Underlying: Common Stock · 1,356 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units ("RSUs") were granted upon Ms. Fontenot's appointment to the Company's Board of Directors on September 16, 2019 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2020 Annual Meeting of Shareholders. At the reporting person's irrevocable election, the number of RSUs identified in this row (i.e., 1,356) will settle on the date of the director's termination of service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-045186 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,711

F1 · kind: The sale of 45,975 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $49.9247 per share. These shares were sold in multiple transactions at prices ranging from $49.50 to $50.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-042165 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,152

F1 · kind: The sale of 773 shares of AMN Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-19-041486 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,925

F1 · kind: The sale of 2,400 shares of AMN Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $55.0089 per share. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-037802 · doc4.xml · nonDerivative · entry 1

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,659

SEC source: 0001209191-19-035880 · doc4.xml · nonDerivative · entry 1

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,358

SEC source: 0001209191-19-030406 · doc4.xml · derivative · entry 5

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 58,184 shares

Expires 2020-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: The exercise of derivative securities reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · derivative.exercise_date: The SSARs set forth in this row were granted on February 2, 2010 pursuant to the AMN Healthcare Equity Plan and vested in three equal installments on the first, second and third anniversary of the grant date.

SEC source: 0001209191-19-030406 · doc4.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,686

F3 · kind: The sale of 29,179 shares of Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in this row represents a weighted average price of $51.0238 per share. These shares were sold in multiple transactions at prices ranging from $50.67 to $51.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-030406 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,865

F2 · shares: A Stock-Settled Appreciation Right ("SSAR") entitles the Grantee to the right to receive shares of AMN's Common Stock ("Stock") having a value equal to the excess of the Fair Market Value of the closing price of the Stock on the trading day prior to the date of exercise over the Exercise Price multiplied by the number of SSARs exercised. The number set forth in this row represents the difference between the number of SSARs exercised (58,184), and the number of shares of Stock issued as a result of the exercise (29,179).

SEC source: 0001209191-19-030406 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,870

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-029570 · doc4.xml · nonDerivative · entry 3

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001209191-19-029570 · doc4.xml · nonDerivative · entry 2

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

SEC source: 0001209191-19-029570 · doc4.xml · nonDerivative · entry 1

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,168

SEC source: 0001209191-19-028414 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,890

F1 · price: The price reported in this row represents a weighted average price of $52.0072 per share. These shares were sold in multiple transactions at prices ranging from $52.03 to $52.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-030406 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,686

F1 · kind: The reporting person transferred 12,000 shares of AMN Common Stock as gifts to charities.

SEC source: 0001209191-19-025402 · doc4.xml · derivative · entry 2

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,907

Underlying: Common Stock · 2,907 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs were granted on April 17, 2019 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2020 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025400 · doc4.xml · derivative · entry 12

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,563 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F15 · derivative.exercise_date: The RSUs set forth in this row were granted on April 13, 2010 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

F9 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025400 · doc4.xml · derivative · entry 11

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,563 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F14 · derivative.exercise_date: The RSUs set forth in this row were granted on April 9, 2009 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

F9 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025400 · doc4.xml · derivative · entry 10

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,009 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F13 · derivative.exercise_date: The RSUs set forth in this row were granted on April 8, 2008 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

F9 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025400 · doc4.xml · derivative · entry 9

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,048 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F12 · derivative.exercise_date: The RSUs set forth in this row were granted on April 18, 2007 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

F9 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025400 · doc4.xml · derivative · entry 8

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,777 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F11 · derivative.exercise_date: The RSUs set forth in this row were granted on July 17, 2006 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

F9 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025400 · doc4.xml · derivative · entry 7

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. The Company's 2019 Annual Meeting of Shareholders was held on April 17, 2019. Accordingly, the number of RSUs identified in this row (2,153) vested on April 17, 2019.

F9 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025400 · doc4.xml · nonDerivative · entry 6

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 13, 2010. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-19-025400 · doc4.xml · nonDerivative · entry 5

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,785

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 9, 2009. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-19-025400 · doc4.xml · nonDerivative · entry 4

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,222

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 8, 2008. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-19-025400 · doc4.xml · nonDerivative · entry 3

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2007. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

SEC source: 0001209191-19-025400 · doc4.xml · nonDerivative · entry 2

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,165

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on July 17, 2006. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.